Shares declined 4% as investors reacted negatively to the cautious outlook driven by delays in government funding and deceleration in revenue growth, despite margin improvements and a solid backlog.

• Q2 revenue plunged to $600K from $10.7M a year ago due to federal government shutdown and delayed contract approvals, with first-half revenue roughly flat at $18.8M vs. $18.9M last year.
• Gross margin improved to 35.2% from 31.3% last year, aided by the completion of loss-making contracts and operational efficiencies.
• Operating expenses rose sharply to $1.7M for the quarter (+$600K YoY) driven by leadership transitions, R&D investments, compliance, and inflationary pressures.
• Adjusted EBITDA declined year-over-year to $2M from $2.4M in Q2, reflecting lower volumes and higher spending.
• Orders and backlog showed modest growth, with backlog at $36.6M, supporting a cautious view that revenue will recover in H2 but remains pressured in the near term.